Robert de Luccia

Robert de Luccia

Net worth: 109 516 $ as of 2026-04-29

80 year
Health Technology
Consumer Durables
Consumer Services

Profile

Mr. Robert J.
de Luccia
is an Executive Chairman at Acurx Pharmaceuticals, Inc. and a Lead Independent Director at IBEX Technologies, Inc. He is on the Board of Directors at PLx Pharma, Inc. and IBEX Technologies, Inc. Mr. de Luccia was previously employed as an Executive Chairman by Dipexium Pharmaceuticals, Inc., a Chairman, President & Chief Executive Officer by MacroChem Corp., a President & Chief Executive Officer by Immunomedics, Inc., a Chief Executive Officer by Morris Plains Property LLC, a Vice President-Marketing & Sales Operations by Pfizer Inc., a President by Sanofi Winthrop, a President by Sanofi-Aventis U.S.
LLC, and a President by Sterling Winthrop, Inc. He also served on the board at Topigen Pharmaceuticals, Inc. He received his undergraduate degree from Iona College and an MBA from Iona College.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-04-19 50,702 ( 3.2% ) 109 516 $ 2026-04-29

Robert de Luccia active positions

CompaniesPositionStart
IBEX TECHNOLOGIES Director/Board Member 1999-12-31
ACURX PHARMACEUTICALS, INC. Founder 2017-06-30
PLX PHARMA WINDDOWN CORP. Director/Board Member 2017-03-31

Former positions of Robert de Luccia

CompaniesPositionEnd
Founder 2017-03-31
Chief Executive Officer 2008-12-31
IMMUNOMEDICS, INC. Chief Executive Officer 1998-12-31
President -
Chief Executive Officer -
See the detail of Robert de Luccia's experience

Training of Robert de Luccia

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

40

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Durables

Consumer Services

Health Technology

Health Technology

Finance

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Robert de Luccia